Organ and tumour dosimetry of 177Lu-rhPSMA-10.1, a novel PSMA-targeted therapy: results from a Phase I trial.

177Lu-rhPSMA-10.1 - Bracco

http://www.ncbi.nlm.nih.gov/pubmed/40325261

Benjamin Fongenie; Daniel Stevens; Hyun Kim; James Nagarajah; Joseph Osborne; Luke Nordquist; Nathaniel Scott; Vikas Prasad

May 6, 2025